Smoke-free advocacy groups raise money for harm reduction and smoking cessation

Jun 16, 2022 Leave a message

The Foundation for a Smoke-Free World is launching a series of funding opportunities under its strategic plan that will guide the foundation's work from 2022 to 2024. As part of its smoking cessation program, the Smoke-Free World Foundation launched an appeal to fund programs related to harm reduction and smoking cessation.

The goal of the organization and its plans for the next few years is to end smoking in this generation. As they explained over the phone, "Since 2018, we have been working closely with a variety of research-focused partners to eliminate combustible smoking and other forms of toxic tobacco in order to reduce related deaths and illness and improve the health of adult users.

As part of its strategy, they have created five funding lines to nurture research on tobacco harm reduction, the products that make it possible, and generally the most effective ways to help smokers quit.

details

The foundation explains, "Five new Requests for Proposals (RFP) have been designed to address priority research and knowledge gaps in smoking cessation and harm reduction. Specifically, these RFPS seek to develop innovative, non-repetitive research programs and protocols to assess the role of tobacco and related product harm reduction in helping smokers to quit or switch. Focus on underserved populations, the impact of regulatory policies on public health, and the impact of nicotine on human health."

Here are 5 ways you can apply for funding:

Efficacy of tobacco harm reduction products as a tool for smokers to discontinue the use of combustible tobacco products.

Intervention for smokers in marginalized and vulnerable communities to quit smoking or switch to tobacco harm reduction products.

Impact of policies and regulations on tobacco harm reduction in low - and middle-income countries.

An organization that evaluates research on the role of nicotine in human health.

Long-term effects of tobacco harm reduction product use on patients with chronic diseases.

The deadline for submitting proposals is Monday, May 16, 2022.